Nasopharyngeal carcinoma

G. Srivastava; A. C.L. Chan; F. C.S. ho; S. L. Loke; S. Pittaluga; Volker Schuster; Hans Wolfgang Kreth; Raphael Feinmesser; Isao Miyazaki; Roy Cheung; Jeremy L. Freeman; Arnold M. Noyek; Hans Michael Dosch

doi:10.1056/NEJM199205073261913

Nasopharyngeal carcinoma

G. Srivastava, A. C.L. Chan, F. C.S. ho, S. L. Loke, S. Pittaluga, Volker Schuster, Hans Wolfgang Kreth, Raphael Feinmesser, Isao Miyazaki, Roy Cheung, Jeremy L. Freeman, Arnold M. Noyek, Hans Michael Dosch

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Abstract

To the Editor: In their study of the feasibility of diagnosing nasopharyngeal carcinoma through the detection of Epstein–Barr virus (EBV) in tissues by means of the polymerase chain reaction (PCR), Feinmesser et al. (Jan. 2 issue)¹ found no detectable EBV DNA in “normal” tonsillar lymphocytes, leukocytes from EBV-seropositive blood donors, or disease-free lymph nodes from patients with other head and neck tumors. Since the incidence of both nasopharyngeal carcinoma and EBV infection in Hong Kong (which is geographically part of southern China) is high, we too have used PCR to look for EBV DNA in tissues from various sites in.

Original language	English
Pages (from-to)	1291-1292
Number of pages	2
Journal	New England Journal of Medicine
Volume	326
Issue number	19
DOIs	https://doi.org/10.1056/NEJM199205073261913
State	Published - 7 May 1992
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJM199205073261913

Cite this

@article{67d446a638264e8793572ab588a43a3a,

title = "Nasopharyngeal carcinoma",

abstract = "To the Editor: In their study of the feasibility of diagnosing nasopharyngeal carcinoma through the detection of Epstein–Barr virus (EBV) in tissues by means of the polymerase chain reaction (PCR), Feinmesser et al. (Jan. 2 issue)1 found no detectable EBV DNA in “normal” tonsillar lymphocytes, leukocytes from EBV-seropositive blood donors, or disease-free lymph nodes from patients with other head and neck tumors. Since the incidence of both nasopharyngeal carcinoma and EBV infection in Hong Kong (which is geographically part of southern China) is high, we too have used PCR to look for EBV DNA in tissues from various sites in.",

author = "G. Srivastava and Chan, {A. C.L.} and ho, {F. C.S.} and Loke, {S. L.} and S. Pittaluga and Volker Schuster and Kreth, {Hans Wolfgang} and Raphael Feinmesser and Isao Miyazaki and Roy Cheung and Freeman, {Jeremy L.} and Noyek, {Arnold M.} and Dosch, {Hans Michael}",

year = "1992",

month = may,

day = "7",

doi = "10.1056/NEJM199205073261913",

language = "אנגלית",

volume = "326",

pages = "1291--1292",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "19",

}

TY - JOUR

T1 - Nasopharyngeal carcinoma

AU - Srivastava, G.

AU - Chan, A. C.L.

AU - ho, F. C.S.

AU - Loke, S. L.

AU - Pittaluga, S.

AU - Schuster, Volker

AU - Kreth, Hans Wolfgang

AU - Feinmesser, Raphael

AU - Miyazaki, Isao

AU - Cheung, Roy

AU - Freeman, Jeremy L.

AU - Noyek, Arnold M.

AU - Dosch, Hans Michael

PY - 1992/5/7

Y1 - 1992/5/7

N2 - To the Editor: In their study of the feasibility of diagnosing nasopharyngeal carcinoma through the detection of Epstein–Barr virus (EBV) in tissues by means of the polymerase chain reaction (PCR), Feinmesser et al. (Jan. 2 issue)1 found no detectable EBV DNA in “normal” tonsillar lymphocytes, leukocytes from EBV-seropositive blood donors, or disease-free lymph nodes from patients with other head and neck tumors. Since the incidence of both nasopharyngeal carcinoma and EBV infection in Hong Kong (which is geographically part of southern China) is high, we too have used PCR to look for EBV DNA in tissues from various sites in.

AB - To the Editor: In their study of the feasibility of diagnosing nasopharyngeal carcinoma through the detection of Epstein–Barr virus (EBV) in tissues by means of the polymerase chain reaction (PCR), Feinmesser et al. (Jan. 2 issue)1 found no detectable EBV DNA in “normal” tonsillar lymphocytes, leukocytes from EBV-seropositive blood donors, or disease-free lymph nodes from patients with other head and neck tumors. Since the incidence of both nasopharyngeal carcinoma and EBV infection in Hong Kong (which is geographically part of southern China) is high, we too have used PCR to look for EBV DNA in tissues from various sites in.

UR - http://www.scopus.com/inward/record.url?scp=0027114121&partnerID=8YFLogxK

U2 - 10.1056/NEJM199205073261913

DO - 10.1056/NEJM199205073261913

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

AN - SCOPUS:0027114121

SN - 0028-4793

VL - 326

SP - 1291

EP - 1292

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 19

ER -

Nasopharyngeal carcinoma

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this